Impact of a novel protocol for atrial fibrillation management in outpatient gastrointestinal endoscopic procedures: a retrospective cohort study

Table 1 Baseline demographics

Characteristics	Group 1 (Pre-Intervention)	Group 2 (Intervention)	p-value
Characteristics	(n = 109)	(n = 141)	p-value
Age, years	70 ± 9	72 ± 9	0.25
Female	32 (29%)	37 (26%)	0.586
Hypertension	80 (73%)	109 (77%)	0.48
Diabetes	30 (28%)	43 (31%)	0.61
EF < 40%	6 (6%)	6 (4%)	0.648
History of stroke	19 (17%)	16 (11%)	0.17
CAD/PVD	25 (23%)	38 (27%)	0.47
New AF Diagnosis, n (%)	8 (7%)	15 (11%)	0.37
Mean CHA₂DS₂VASc in all patients	2.99	3.05	0.78
Mean CHA₂DS₂VASc in new AF patients	2.00	3.27	0.09
Average SBP	128	129	0.53
Average DBP	72	72	0.88
Average HR	76	74	0.32

AF atrial fibrillation, CAD coronary artery disease, CHA₂DS₂VASc congestive heart failure, hypertension, age, diabetes, stroke/transient ischemic attack/thromboembolism, vascular disease, age 65–75 years, sex category, EF ejection fraction, PVD peripheral vascular disease, HR heart rate, SBP systolic blood pressure, DBP diastolic blood pressure. Values are mean ± standard deviation for continuous data and n (%) for categorical data

ISSN: 1471-2261